Correlation Between Immunome and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Immunome and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunome and Inhibrx, you can compare the effects of market volatilities on Immunome and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and Inhibrx.
Diversification Opportunities for Immunome and Inhibrx
Significant diversification
The 3 months correlation between Immunome and Inhibrx is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Immunome i.e., Immunome and Inhibrx go up and down completely randomly.
Pair Corralation between Immunome and Inhibrx
Given the investment horizon of 90 days Immunome is expected to under-perform the Inhibrx. In addition to that, Immunome is 1.36 times more volatile than Inhibrx. It trades about -0.11 of its total potential returns per unit of risk. Inhibrx is currently generating about -0.01 per unit of volatility. If you would invest 1,514 in Inhibrx on December 29, 2024 and sell it today you would lose (82.00) from holding Inhibrx or give up 5.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Immunome vs. Inhibrx
Performance |
Timeline |
Immunome |
Inhibrx |
Immunome and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immunome and Inhibrx
The main advantage of trading using opposite Immunome and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
Inhibrx vs. Mirum Pharmaceuticals | Inhibrx vs. Rocket Pharmaceuticals | Inhibrx vs. Avidity Biosciences | Inhibrx vs. Uniqure NV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |